Partner Event:
China Healthcare Summit
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.


Written by Richard Daverman, PhD.

Click a link below to view the mailing archive as if it had been sent to you.

2011-10-31 01:30Roche's Strategy for China - Global, Not Local
2011-10-30 01:30The Week in Review: BioBay Park Forms Partnership with Roche and Harvard
2011-10-29 01:30Gates Foundation and China Form $300 Million Drug and Agriculture Partnership
2011-10-28 01:30China to Up Vaccine Protection against Epidemics and more...
2011-10-27 01:30Lepu Medical Invests $15.6 Million to Increase Medical Device Capacity
2011-10-26 01:30Novartis Transferring Jobs from Europe/US to China and India and more...
2011-10-25 01:30BioBay, Roche and Harvard Form Novel Cancer Drug Partnership and more...
2011-10-23 01:30The Week in Review: SFDA Releases 2010 Approval Data
2011-10-22 01:30SFDA Annual Report of Drug Registration Approvals -- 2010
2011-10-21 01:30Simcere Partners Up with Suzhou NeuPharma on Cancer Drug and more...
2011-10-20 01:30CEO of Hutchison MediPharma Quietly Steps Back and more...
2011-10-19 01:30Zhuhai Hokai Medical Instruments Completes ChiNext IPO
2011-10-18 01:30Lundbeck Sets Up Research Center in Shanghai
2011-10-16 01:30The Week in Review: Pharma Execs Plan Future at ChinaBioÔö£éÔö¼?½ Leadership Retreat-Taicang
2011-10-15 01:30WuXi Buys Abgent, a US-China Antibody Maker and more...
2011-10-14 01:30ViroMed's Gene Therapy Drug Given SFDA Approval for Phase II Trial and more...
2011-10-13 01:30China Life Science Leaders Discuss the Future at ChinaBioÔö£éÔö¼?½ Leadership Retreat
2011-10-12 01:30Chiva Pharma Acquires Global Rights to Osteoporosis Drug from Ligand and more...
2011-10-11 01:30AstraZeneca to Build $200 Million Manufacturing Plant in China Medical City and more...
2011-10-09 01:30The Week in Review: Bailing Group Pharma Acquires Zhengxin Pharma
2011-10-08 01:30China Attacks Antibiotic Overuse, Putting Pressure on Makers' Stock Prices
2011-10-07 01:30India Takes Aim at China Pharma's Inroads into the Indian Market
2011-10-06 01:30SciClone Announces $20 Million Stock Buyback
2011-10-05 01:30GSK Seeking Up to $2B Bolt-on Acquisitions in India
2011-10-04 01:30Guizhou Bailing Buys Another Ethnic-Miao TCM Company
2011-10-02 01:30The Week in Review: Newsummit Announces $100 Million Medical Device Fund
2011-10-01 01:30Nycomed/Takeda Adds Antihistamine to China Portfolio

 

<< Archive IndexSubscribe >>


Not a ChinaBio®Today Subscriber?

Here's what you get with a paid subscription to ChinaBio® Today:
  • Website access to all current articles and commentary
  • Full access to over 2000 archived articles on the biotech industry

ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC